Journal of Medical Virology · 2009 · 55 citations · 32 references
Life SciencesImmunologyInfectious DiseasesInflammationInnate ImmunityMolecular ImmunologyAntiviral ImmunityDeath ReceptorsInnate Immune ActivationInnate Immune Signaling PathwaysViral InfectionsViral PathogenesisAntiviral Innate Immune SignalingAntiviral Innate SignalingChemotactic SignalingDendritic Cell Activation SignalingDendritic Cell Antiviral ResponsesDengue FeverDengue Hemorrhagic FeverProtein Expression Levels
We used gene expression profiling of human primary cells infected in vitro with dengue virus (DENV) as a tool to identify secreted mediators induced in response to the infection. Affymetrix GeneChip analysis of human primary monocytes, B cells and dendritic cells infected with DENV in vitro showed strong induction of monocyte chemotactic protein 2 (MCP-2/CCL8), interferon gamma-induced protein 10 (IP-10/CXCL10) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/TNFSF10). The expression of these genes was confirmed in dendritic cells infected with DENV in vitro at mRNA and protein levels. A prospectively enrolled cohort of DENV-infected Venezuelan patients was used to measure the levels of these proteins in serum during three different periods of the disease. Results showed significant increase of MCP-2, IP-10, and TRAIL levels in patients infected with DENV during the febrile period, when compared to healthy donors and patients with other febrile illnesses. MCP-2 and IP-10 levels were still elevated during the post-febrile period while TRAIL levels dropped close to normal after defervescense. Patients with primary infections had higher TRAIL levels than patients with secondary infections during the febrile period of the disease. Increased levels of IP-10, TRAIL and MCP-2 in acute DENV infections suggest a role for these mediators in the immune response to the infection. MCP-2 was identified in this work as a new unreported and important dengue-related protein and IP-10 was confirmed as a novel and strong pro-inflammatory marker in acute disease.
32
Summaries of Affymetrix GeneChip probe level data
Rafael A. Irizarry · Nucleic Acids Research · 2003 · 5K citations · Full text
Safety and antitumor activity of recombinant soluble Apo2 ligand
Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17
R. S. Lanciotti, Charles H. Calisher, Duane J. Gubler et al. · Journal of Clinical Microbiology · 1992 · 1.9K citations · Full text
Mig and IP-10: CXC chemokines that target lymphocytes
Joshua Μ. Farber · Journal of Leukocyte Biology · 1997 · 793 citations